KR970025608A - Soft sugar dragee and manufacturing method - Google Patents

Soft sugar dragee and manufacturing method Download PDF

Info

Publication number
KR970025608A
KR970025608A KR1019950040230A KR19950040230A KR970025608A KR 970025608 A KR970025608 A KR 970025608A KR 1019950040230 A KR1019950040230 A KR 1019950040230A KR 19950040230 A KR19950040230 A KR 19950040230A KR 970025608 A KR970025608 A KR 970025608A
Authority
KR
South Korea
Prior art keywords
vitamin
soft
sugar
dragee
dispersing agent
Prior art date
Application number
KR1019950040230A
Other languages
Korean (ko)
Inventor
장민수
Original Assignee
장민수
청계약품 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 장민수, 청계약품 주식회사 filed Critical 장민수
Priority to KR1019950040230A priority Critical patent/KR970025608A/en
Publication of KR970025608A publication Critical patent/KR970025608A/en

Links

Abstract

본 발명은 생균을 함유한 의약품 또는 기능성 식품으로서 사용되는 씹어먹는 연질 당의정 및 그 제조방법에 관한 것으로서, 종래의 경우에는 공기중의 산소 및 습기에 의하여 그 안정성이 떨어지는 것은 물론 타정 및 코팅 과정중의 높은 온도로 인하여 생균의 안정성이 떨어져 제품의 개발이 어려운 문제점등이 있었는 바, 이를 감안하여 생균제를 연질 당의정으로 함으로써 산제, 관립제, 정제에서의 생균의 안정성을 보존하고, 일반 코팅정에서의 제제시 생균의 생존율 저하를 방지하며, 시간과 장소에 관계없이 의약 또는 식품으로서 물없이 쉽게 복용할 수 있는 안정성 및 편익성을 겸비한 연질 당의정 및 그 제조방법을 제공함에 있다.The present invention relates to a chewable soft dragee used as a pharmaceutical or functional food containing live bacteria, and a method for manufacturing the same, in the conventional case, the stability of which is lowered by oxygen and moisture in the air, as well as during the tableting and coating process. Due to the high temperature, there is a problem that the development of the product is difficult due to low stability of live bacteria.In view of this, the probiotic is made into soft dragee to preserve the stability of live bacteria in powders, granules and tablets. The present invention provides a soft sugar-coated tablet and a method of manufacturing the same, which prevent the degradation of viable microorganisms and have stability and convenience that can be easily taken without water as a medicine or food regardless of time and place.

Description

연질 당의정 및 그 제조방법Soft sugar dragee and manufacturing method

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (7)

정장작용이 있는 생균을 연질 당의정으로 하여 씹어먹을 수 있게 당의 조성한 연질 당의정.Soft sugar made of sugar so that it can be chewed by using live bacteria with a formal action as a soft sugar made. 제1항에 있어서, 생균은 크로스트리움 브티리쿰, 스트랩토코카스 훼시움, 바실러스 서브틸리스, 락토바실러스 아시도필루스, 락토바실러스 비퍼더스, 락토바실러스 스포로게네스등에 속하는 장내 유익세균종의 군에서 선택된 적어도 1종균에 비타민 B1, B2, B3, B5, B6, B12C를 1종 이상 혼합됨을 특징으로 하는 연질 당의정.The group of intestinal beneficial bacteria according to claim 1, wherein the live bacteria belong to Crosstrium vitalisum, Straptococcus fascium, Bacillus subtilis, Lactobacillus asidophilus, Lactobacillus beepferus, Lactobacillus sporogenes and the like. Soft sugar dragee, characterized in that at least one species of vitamin B 1 , B 2 , B 3 , B 5 , B 6 , B 12 C selected from at least one species. 제2항에서 1정당 생균은 1×104~1×1011개이고, 비타민 B1는 0.1∼l0mg, 비타민 B2는 0.1∼10mg, 비타민 B3는 0.1~40mg, 비타민 B5는 0.5-l0mg, 비타민 B6는 0.1∼40mg, 비타민 B12는 01. ∼400μm, 비타민 C는 1∼200mg 혼합됨을 특징으로 하는 연질 당의정.In claim 2 wherein one party of viable cells is 1 × 10 4 ~ 1 × 10 11 pieces, vitamin B 1 is 0.1~l0mg, vitamin B 2 is 0.1~10mg vitamin B 3 is 0.1 ~ 40mg, Vitamin B 5 is 0.5-l0mg , Vitamin B 6 is 0.1 ~ 40mg, Vitamin B 12 is 01. ~ 400μm, Vitamin C is characterized in that 1-200mg mixed soft sugar drag. 생균과 비타민으로 중심정을 제조하고 코팅기제로 방수코팅한 다음 산포제로 서브코팅하고 시럽액으로 스므딩한 다음 색소액으로 칼러링하는 단계로 구성됨을 특징으로 하는 성분의 연질 당의정을 제조하는 방법.A method for producing a soft sugar-coated tablet comprising the steps of preparing a central tablet with probiotics and vitamins, waterproof coating with a coating agent, subcoating with a dispersing agent, smoothing with syrup solution, and coloring with a pigment solution. 제4항에 있어서, 당의시 사용되는 수용성 산포제는 백당, 포도당, 과당, 만니톨, 텍스트린, 솔비톨 및 올리고당등으로부터 1종 이상 선택되고 산포제중 10% 미만 사용되는 수불용성 산포제는 탈크, 침감탄산칼슘, 카올린 및 황산칼슘등으로부터 1종 이상 선택됨을 특징으로 하는 연질 당의정을 제조하는 방법.The water-insoluble dispersing agent according to claim 4, wherein the water-soluble dispersing agent used in dragging is selected from at least one selected from white sugar, glucose, fructose, mannitol, textine, sorbitol, oligosaccharide, and the like, and less than 10% of the dispersing agent is talc, A method for producing a soft dragee, characterized in that at least one selected from precipitated calcium carbonate, kaolin, calcium sulfate and the like. 제4항에 있어서, 서브코팅 및 스므딩용으로 사용되는 시럽은 백당, 포도당, 과당, 만니톨, 텍스트린, 솔비톨 및 올리고당등으로부터 1종 이상 선택됨을 특징으로 하는 연질 당의정을 제조하는 방법.The method of claim 4, wherein the syrup used for the sub-coating and the smoothing is selected from at least one selected from white sugar, glucose, fructose, mannitol, textine, sorbitol, oligosaccharide, and the like. 제4항에 있어서, 스프레이법으로 당의시 사용되는 스프레이액은 백당, 포도당, 과당, 만니톨, 텍스트린, 솔비톨 및 올리고당으로부터 1종 이상 선택되고 10% 미만 사용되는 수불용성 현탁제는 탈크, 침강탄산칼슘, 전분, 카올린 및 황상칼슘등으로부터 1종 이상 선택됨을 특징으로 하는 연질 당의정을 제조하는 방법.The water-insoluble suspending agent according to claim 4, wherein the spray liquid used for dragging in the spraying method is selected from at least one selected from white sugar, glucose, fructose, mannitol, textine, sorbitol, and oligosaccharide and used less than 10% of talc, precipitated carbonic acid. A method for producing a soft dragee, characterized in that at least one selected from calcium, starch, kaolin and calcium sulfate. ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950040230A 1995-11-08 1995-11-08 Soft sugar dragee and manufacturing method KR970025608A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950040230A KR970025608A (en) 1995-11-08 1995-11-08 Soft sugar dragee and manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950040230A KR970025608A (en) 1995-11-08 1995-11-08 Soft sugar dragee and manufacturing method

Publications (1)

Publication Number Publication Date
KR970025608A true KR970025608A (en) 1997-06-24

Family

ID=66587488

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950040230A KR970025608A (en) 1995-11-08 1995-11-08 Soft sugar dragee and manufacturing method

Country Status (1)

Country Link
KR (1) KR970025608A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100344198B1 (en) * 1999-10-08 2002-07-19 일양약품주식회사 Composition of sildenafil citrate dosage form
KR100493413B1 (en) * 1997-11-27 2005-09-30 에스케이케미칼주식회사 Chewable film coating composition and preparation method using the same
KR20090021584A (en) * 2007-08-27 2009-03-04 비타민하우스(주) Tablet comprising vitamin c and manufacturing method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100493413B1 (en) * 1997-11-27 2005-09-30 에스케이케미칼주식회사 Chewable film coating composition and preparation method using the same
KR100344198B1 (en) * 1999-10-08 2002-07-19 일양약품주식회사 Composition of sildenafil citrate dosage form
KR20090021584A (en) * 2007-08-27 2009-03-04 비타민하우스(주) Tablet comprising vitamin c and manufacturing method thereof

Similar Documents

Publication Publication Date Title
Silva et al. Symbiotic microencapsulation to enhance Lactobacillus acidophilus survival
KR101289413B1 (en) Oral form of administration containing probiotic bacteria
TW414807B (en) Maltose-trehalose converting enzyme, and preparation and uses thereof
CN103547670B (en) New lactic acid bacteria and the composition of the bacteria resistance flu containing it
CN101056972B (en) Means and methods for preventing and/or treating caries
Macfarlane et al. Consequences of biofilm and sessile growth in the large intestine
JP3921175B2 (en) Composition for prevention and / or treatment of oral disease
EP1917960A1 (en) Improved biological effects of rosmarinic acid
CN104814983A (en) Uses and methods for preventing and/or treating caries caused by mutants streptococci
SE506529C2 (en) Use of a lactoperoxidase system for the preparation of a drug against Helicobacter pylori
DE19826928A1 (en) Medicines containing viable anaerobic bacteria that inhibit sulfate reduction by sulfate-reducing bacteria
DE19961182A1 (en) Galactomannan oligosaccharides and processes for their preparation and their use
US4782045A (en) Promoting the proliferation of intestinal bifidobacteria
CN109966321A (en) The composition being used for from particulate matter toxicity protection cell and tissue comprising lactobacillus casei bacterial strain
CN101505721A (en) Anti-wrinkle agent
MXPA02000630A (en) Oral form of administration containing probiotic micro-organisms.
US8475786B2 (en) Long-lasting absorption of flavonoids
CN109497555A (en) A kind of sophorose microcapsules and its preparation method and application
Wood The state of hexose sugar in human dental plaque and its metabolism by the plaque bacteria
CN112263503A (en) Application of sialic acid in inhibiting melanin formation and oral whitening products
KR970025608A (en) Soft sugar dragee and manufacturing method
CN100534438C (en) Difructose anhydride-containing composition and use thereof
KR20220075624A (en) Lactobacillus pentosus OKBL-L.PE 1 strain having antioxidant activity, anti-inflammatory activity, skin whitening activity, antimicrobial activity against pathogenic microorganism and anti-thrombotic activity and uses thereof
CN109645473A (en) A kind of composition and its application improving gastrointestinal tract and strengthen immunity
KR20050105669A (en) Probiotic composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application